-
MELBOURNE: Fourth India-Australia 2+2 Secretary-level Consultations - November 3, 2024
-
TORONTO: India’s response to diplomatic communication from Canada - November 2, 2024
-
NGERULMUD: Shri Harsh Kumar Jain concurrently accredited as the next Ambassador of India to the Republic of Palau - November 1, 2024
-
DHAKA: Statement on attack on Puja Mandap and desecration and damage to Hindu temples in Bangladesh - October 31, 2024
-
KINGSTON: Shri Subhash Prasad Gupta concurrently accredited as the next High Commissioner of India to St.Vincent and the Grenadines - October 30, 2024
-
STOCKHOLM: Dr. Neena Malhotra appointed as the next Ambassador of India to the Kingdom of Sweden - October 29, 2024
-
BEIRUT: Statement on recent developments in southern Lebanon - October 29, 2024
-
BANGKOK: Meeting of Prime Minister with Prime Minister of Thailand - October 28, 2024
-
NEW YORK: H1B Visa “Thing Of Past”: Union Minister Piyush Goyal After US Visit - October 28, 2024
-
MOSCOW: Prime Minister meets with the President of the Russian Federation - October 27, 2024
NOUAKCHOTT : India offers support for Africa to fight the Omicron variant
NOUAKCHOTT : We have noted the emergence of a new variant of Covid-19, Omicron. We express our solidarity with the countries, particularly in Africa, who have so far been affected by the Omicron variant.
The Government of India stands ready to support the countries affected in Africa in dealing with the Omicron variant, including by supplies of Made-in-India vaccines. Supplies can be undertaken through COVAX or bilaterally. In this regard, the Government has cleared all orders placed so far by COVAX for supplies of COVISHIELD vaccines including to African countries like Malawi, Ethiopia, Zambia, Mozambique, Guinea and Lesotho. We have also cleared supplies of COVAXIN to Botswana. Any new requirement projected either bilaterally or through COVAX will be considered expeditiously.
India also stands ready to supply essential life-saving drugs, test kits, gloves, PPE kits and medical equipment such as ventilators, as may be required. Indian institutions would favourably consider cooperation in genomic surveillance and virus characterization related research work with their African counterparts.
India has, so far, supplied more than 25 million doses of Made-in-India vaccines to 41 countries in Africa, including nearly 1 million doses as grant to 16 countries and more than 16 million doses under the COVAX facility to 33 countries.]